Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) Research & Development (2017 - 2025)

Si-Bone (SIBN) has 8 years of Research & Development data on record, last reported at $4.4 million in Q4 2025.

  • For Q4 2025, Research & Development rose 12.74% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $17.4 million, up 5.36%, while the annual FY2025 figure was $17.4 million, 5.36% up from the prior year.
  • Research & Development reached $4.4 million in Q4 2025 per SIBN's latest filing, up from $4.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $4.5 million in Q1 2025 and bottomed at $3.0 million in Q1 2021.
  • Average Research & Development over 5 years is $3.8 million, with a median of $3.8 million recorded in 2023.
  • Peak YoY movement for Research & Development: skyrocketed 45.45% in 2021, then dropped 8.07% in 2023.
  • A 5-year view of Research & Development shows it stood at $3.0 million in 2021, then rose by 14.14% to $3.5 million in 2022, then rose by 19.6% to $4.2 million in 2023, then decreased by 7.02% to $3.9 million in 2024, then rose by 12.74% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $4.4 million in Q4 2025, $4.2 million in Q3 2025, and $4.3 million in Q2 2025.